Max Wallace, CEO of Accelerate Brain Cancer Cure (ABC2), spent most of his career starting and building successful biotechnology companies. His expertise in drug discovery, innovation and development make him a sought-after speaker at biomedical industry conferences across the country.
In his leadership role at ABC2, Max takes advantage of these speaking opportunities to meet new collaborators and to discover novel approaches that could help ABC2 develop better brain cancer treatments and spark a research revolution, "We're always on the hunt for interesting ideas and entrepreneurial people that share our sense of urgency and willingness to invest in high-risk, high-reward research with potential for big impacts."
On November 1st, Max mentored a select group of biotech startups at the EARLY/Stage program held at the 13th Annual SEBIO Investor Forum held in Durham, North Carolina. Nearly 400 people attended South East BIO's premier life sciences conference. Max, along with active venture capitalists, entrepreneurs and angel investors, worked one-on-one with the young companies to help them hone their business plans. "We wanted Max on our mentoring team because he knows what it takes to bring a drug to market and build a successful company," said Tina Williams McKeon, Co-Chair, SEBIO 2011 EARLY/Stage Committee. "Sharing his experiences goes a long way toward enhancing the development of these emerging enterprises."
On November 8th, Max spoke at the Florida State University's "Business of Life Sciences" symposium. The symposium explored how science gets to the patient, the clinic and the public. Max's talk, "Navigating Today's Rough Terrain: Innovation at the Crossroads of Science, Funding, Industry and Society," was well-received by the hundreds of FSU faculty, postdocs and Ph.D students in the life sciences.
